SAN FRANCISCO, California (October 7, 2025) — Grove AI, a company advancing the next generation of intelligent automation for life sciences with agentic AI, today announced the launch of Agent Operator, an end-to-end agentic AI system that enables life sciences organizations to automate complex operational workflows across clinical trials, patient services, patient safety, and more with AI agents.

Agent Operator currently powers Grace, Grove AI’s industry-leading AI agent for participant recruitment. Over the past year, Grace has automated more than 1,000,000 participant prescreening and enrollment interactions across 50+ pivotal Phase II and III clinical trials in eight therapeutic areas.

With this launch, Agent Operator builds on Grove AI’s leadership in clinical trial automation and expands access to the company’s enterprise platform, enabling more life sciences teams to accelerate their workflows with agentic AI. This expansion underscores Grove AI’s commitment to advancing the broader life sciences ecosystem with secure, compliant agentic AI. To learn more, visit grovetrials.com/operator.